Log in
Enquire now
‌

US Patent 9631029 Anti-ADAMTS-5 antibody, derivatives and uses thereof

Patent 9631029 was granted and assigned to Rottapharm on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Rottapharm
Rottapharm
Current Assignee
Rottapharm
Rottapharm
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9631029
Patent Inventor Names
Gianfranco Caselli0
Riccardo Chiusaroli0
Michela Visintin0
Lucio Claudio Rovati0
Date of Patent
April 25, 2017
Patent Application Number
14390466
Date Filed
April 12, 2013
Patent Citations Received
‌
US Patent 11661460 Anti-coagulation factor XI antibodies
0
Patent Primary Examiner
‌
Maher Haddad
Patent abstract

The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognize and bind an epitope comprised in the spacer domain of ADAMTS-5, nucleic acid and expression vector encoding the same, method of production and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9631029 Anti-ADAMTS-5 antibody, derivatives and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.